New Delhi metallo-b-lactamase (NDM)-1 carbapenemase-producing bacteria are resistant to antibiotics of the carbapenem family, which are used as a last resort for the treatment of infectious diseases caused by drugresistant bacteria. Therefore, the emergence of these bacteria presents a serious public health issue. This is particularly true given that NDM-1 carbapenemase has been detected in many clinical isolates worldwide since it was first identified in clinical isolates of Klebsiella pneumoniae and Escherichia coli from a patient hospitalized in New Delhi (1). The NDM-1 carbapenemase gene has been predominantly identified in Enterobacteriaceae, but it can also occur in non-fermenters (2). Hence, it is necessary to monitor the emergence and spread of NDM-1 producers with a convenient and effective screening method.
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NDM-1 carbapenemase is a class B zinc metallo-blactamase (MBL) (3) . A variety of techniques have already been developed to detect MBL producers (4), including a disk-based synergy test, the sodium mercaptoacetate (SMA) test, which is conventionally used in Japanese clinical microbiology laboratories (5) . This test uses a Kirby-Bauer (KB) disk containing a b-lactam antibiotic (ceftazidime [CAZ] recommended) and a disk containing SMA, an MBL inhibitor that can bind to the MBL active site through interactions with zinc ions (6) . Although this test works well for the detection of IMPand VIM-type MBL producers, which are the predominant MBL types in Japan (7), preliminary results have indicated that it may fail to detect NDM-1 producers when using the SMA test with the CAZ disk according to general recommendations (8) . Hence, the present study aimed at improving the SMA test by replacing the CAZ disk for detecting NDM-1 producers among Enterobacteriaceae and Acinetobacter baumannii.
A collection of 15 NDM-1-positive bacterial isolates (5 E. coli, 4 K. pneumoniae, 1 Enterobacter cloacae, 1
Citrobacter freundii, and 4 A. baumannii), obtained from hospitals in Vietnam in 2010, and 1 NDM-1-positive K. pneumoniae strain (MRY10-722) isolated in a hospital in Japan in 2010, were used in this study. These isolates were identified using the API 20E and Vitek2 systems (bioMerieux, Marcy l'Etoile, France). Identification of A. baumannii isolates was further confirmed by rpoB gene sequencing (9) . The NDM-1 gene was detected using PCR analysis with specific primers as described previously (10) .
A total of 16 isolates were subjected to the SMA test. The inhibitory effect of CAZ was compared with that of the carbapenems, imipenem (IPM) and meropenem (MPM). Suspensions of the bacterial isolates were adjusted and spread on Mueller-Hinton agar plates according to the protocol recommended by the Clinical and Laboratory Standards Institute guidelines (11) . The KB disks containing b-lactam antibiotics (CAZ [30 mg] or IPM [10 mg] or MPM [10 mg]) (Eiken Chemical Co., Ltd., Tokyo, Japan) were placed on the plates, and disks containing SMA (3 mg) (Eiken Chemical) were placed close to 1 b-lactam disk as shown in Fig. 1 . The center-to-center diameter between the KB disk and the SMA disk was 16 mm. The plate was incubated at 359 C for 18 h and the growth-inhibitory zone around the KB disk close to the SMA disk was compared with that around the KB disk alone. An isolate was considered MBL-positive when an apparent expansion was observed, i.e., an enlargement of 5 mm or greater of the growth-inhibitory zone around the KB disk close to the SMA disk compared with that around the KB disk alone (Fig. 1, middle and lower panels) . An isolate was considered MBL-negative if there was no expansion of the growth-inhibitory zone or if the expansion was less than 5 mm (Fig. 1, upper panel) .
The results are summarized in Table 1 . The highest sensitivity was obtained with a combination of the MPM and SMA disks. Of the 16 strains, 15 (93.8z) were confirmed as positive. The combination of the IPM and SMA disks resulted in the positive identification of 14 strains (87.5z). On the other hand, a combination of the CAZ and SMA disks was considerably less sensitive, as only 7 strains (43.8z) had positive results.
These results indicated that the carbapenems, IPM and MPM, are generally more suitable than CAZ for 
SMA, sodium mercaptoacetate; NDM, New Delhi metallo-b-lactamase; CAZ, ceftazidime; IPM, imipenem; MPM, meropenem; ＋, positive; -, negative.
detecting NDM-1-producing bacteria. The low sensitivity of the CAZ disk could be ascribed to the coproduction of other b-lactamases such as extended-spectrum blactamases and plasmid-mediated or chromosomally encoded AmpC b-lactamases, which inactivate CAZ without being inhibited by SMA. In fact, it has been reported that NDM-1-producers often simaultaneously carry other b-lactamase genes, such as bla CTX-M , bla CMY , or bla DHA (12, 13) . Nevertheless, 1 E. cloacae isolate (V-87) produced a clearly enlarged inhibitory zone between the SMA and CAZ disks but not between SMA and MPM or IPM, suggesting the importance of CAZ.
We hypothesized that these findings may have been owing to the coproduction of OXA-48 carbapenemase, which is usually resistant to MPM but not to CAZ. The OXA-48 carbapenemase is a member of the serine-blactamases, whose activities are not inhibited by SMA.
We used PCR to screen all isolates for the presence of bla OXA-48 . As expected, only the E. cloacae isolate V-87 carried the bla OXA-48 gene; however, further examinations with additional isolates are required to confirm our hypothesis. On the basis of these results, we conclude that the SMA test using both the MPM and CAZ disks is the most suitable method for screening carbapenemresistant isolates for NDM-1-type MBL producers. As reported previously (8) , this combination also allows for highly sensitive and specific detection of the IMP-and VIM-type MBL producers. Effective screening of MBL producers, including the NDM-1 type and other MBL types, can therefore be performed by the SMA test using MPM and CAZ disks in clinical laboratories followed by confirmation of the MBL genes by PCR analysis in specialized laboratories.
